|
|
||||||||||||||||
Prompt treatment with relatively cheap and effective drugs can prevent deaths from malaria. So why does this disease still cause more deaths than any other throughout Tanzania? The growth in the use of modern medicines has reduced the delaying impact of traditional remedies. The introduction of the 'integrated management of childhood illness' approach, which focuses on the overall wellbeing of a child, is crucial in reducing malaria deaths The persistently high mortality rates from malaria suggest that a barrier exists in the pathway to effective care in Tanzania. Around 90 percent of Tanzanians live within one hour of government health services, where care for children under five years old is free. Do parents, relatives and other carers use these services when children develop malaria and can they get access to them in time? This research by the Tanzanian Ministry of Health's Essential Health Intervention Project (TEHIP) looks at care-seeking for 320 children under five who died from malaria in the Rufiji District of Coast Region, southern Tanzania. The results from a demographic surveillance system with follow-up for all deaths revealed that:
More than half of cases seek care two or more times for the same illness from different types of provider. This is more common with convulsions. In malaria deaths where care is accessed more than once, modern care is the first or second resort for at least 90 percent of cases. This study shows that traditional remedies are no longer a significant delaying factor in accessing modern treatment for life-threatening malaria in Tanzania. At the time of this study, all government providers in Rufiji had adequate drug supplies and offered integrated management of childhood illness (IMCI). This could be a factor in the popularity of government providers. However, the first line anti-malarial in use was chloroquine for which drug resistance was common. Most care-givers now include modern care early in their search for treatment for eventually severe and fatal malaria. And yet many children are still dying. The recent introduction of IMCI into the study area and replacement of chloroquine with sulfadoxine-pyrimethamine as the first-line drug treatment are important steps to reduce malaria mortality. The researchers also recommend:
Source(s): Funded by: International Development Research Centre, Canada; UK Department for International Development; US Centers for Disease Control; National Academy of Sciences, Institute of Medicine id21 Research Highlight: 31 March 2005
Further Information: Tel:
+41 61 284 8160 Tanzania Essential Health Intervention Project
International Development Research Centre (IDRC), Canada Other related links:
|
|
|||||||||||||||
|
|
|
|
|
|
||||||||||||